Gene · 10507
Papers1,823
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 1,823
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Dynamic crosstalk between HSCs and liver microenvironment: multicellular interactions in the regulation of liver fibrosis. | Front Cell Dev Biol | 2025 | 40761743 | PubTator, text mining | PubMed |
| Causal associations between smoking and ocular diseases: a Mendelian randomization study. | Adv Ophthalmol Pract Res | 2025 | 40746870 | PubTator, text mining | PubMed |
| Sema4D combined with electrocardiographic parameters for predicting STEMI prognosis: Development and validation of a nomogram model. | Medicine (Baltimore) | 2025 | 40660574 | PubTator, text mining | PubMed |
| Regulation of Vascular Calcification by M1-Type Macrophage-Derived Semaphorin 4D. | Int J Mol Sci | 2025 | 40507881 | PubTator, text mining | PubMed |
| Improving reline bonding in 3D-printed dentures: an experimental in vitro study. | J Dent | 2025 | 40460970 | PubTator, text mining | PubMed |
| Multi-tissue expression and splicing data prioritise anatomical subsite- and sex-specific colorectal cancer susceptibility genes. | Nat Commun | 2025 | 40447568 | PubTator, text mining | PubMed |
| Ligand-receptor dynamics in heterophily-aware graph neural networks for enhanced cell type prediction from single-cell RNA-seq data. | Front Mol Biosci | 2025 | 40421418 | PubTator, text mining | PubMed |
| Research Advances in the Immunomodulatory Functions of CD100/SEMA4D and Their Roles in Viral Infectious Diseases. | Int J Mol Sci | 2025 | 40362578 | PubTator, text mining | PubMed |
| Molecular and immune landscape of melanoma: a risk stratification model for precision oncology. | Discov Oncol | 2025 | 40319421 | PubTator, text mining | PubMed |
| Prognostic and Immunotherapeutic Value of Regulatory T Cell Marker Gene Signature in Melanoma. | Iran J Allergy Asthma Immunol | 2025 | 40211502 | PubTator, text mining | PubMed |
| Corrigendum: Biostimulation of indigenous microbial community for bioremediation of petroleum refinery sludge. | Front Microbiol | 2025 | 40182287 | PubTator, text mining | PubMed |
| Smoking aggravates neovascular age-related macular degeneration via Sema4D-PlexinB1 axis-mediated activation of pericytes. | Nat Commun | 2025 | 40121188 | PubTator, text mining | PubMed |
| Pepinemab: a SEMA4D antagonist for treatment of Huntington's and other neurodegenerative diseases. | Expert Opin Investig Drugs | 2025 | 40007468 | PubTator, text mining | PubMed |
| Practical Utility of Serum Ammonia in Children With Acute Liver Failure: A Biomarker of Outcome. | Transplant Direct | 2025 | 39995961 | PubTator, text mining | PubMed |
| Potential drug targets for ovarian cancer identified through Mendelian randomization and colocalization analysis. | J Ovarian Res | 2025 | 39972314 | PubTator, text mining | PubMed |
| [Elucidating the Pathophysiology of Various Diseases by Investigating the Role of Molecules in Brain Wiring]. | Yakugaku Zasshi | 2025 | 39894482 | PubTator, text mining | PubMed |
| Semaphorin-4D signaling in recruiting dental stem cells for vascular stabilization. | Stem Cell Res Ther | 2025 | 39865283 | PubTator, text mining | PubMed |
| Effect of Air Particle Abrasion and Primers on Bond Strength to 3D-Printed Crown Materials. | Materials (Basel) | 2025 | 39859736 | PubTator, text mining | PubMed |
| Downregulation of N6-methyladenosine (m6A) methylation of Sema4D mRNA contributes to Treg dysfunction and allograft rejection. | Am J Transplant | 2025 | 39848338 | PubTator, text mining | PubMed |
| Soluble CD72 concurrently impairs T cell functions while enhances inflammatory response in sepsis. | Int Immunopharmacol | 2025 | 39793226 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10507/papers?page=4